Accéder au contenu
Merck
Toutes les photos(1)

Key Documents

PHR1842

Supelco

Fluticasone Related Compound A

Pharmaceutical Secondary Standard; Certified Reference Material

Synonyme(s) :

6ALPHA,9-DIFLUORO-11BETA-HYDROXY- 16ALPHA-METHYL-3-OXO-17 (PROPANOYLOXY)ANDROSTA-1,4-DIEN- 17BETA-CARBO(THIOPEROXOIC)SO-ACID (Fluticasone Related Compound A) (Fluticasone Impurity B), 6ALPHA,9-DIFLUORO-11BETA-HYDROXY- 16ALPHA-METHYL-3-OXO-17 (PROPANOYLOXY)ANDROSTA-1,4-DIEN- 17BETA-CARBO(THIOPEROXOIC)SO-ACID, ((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-17-(propionyloxy)-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthrene-17-carbo(thioperoxoic)o-acid)

Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme


About This Item

Formule empirique (notation de Hill):
C24H30F2O6S
Numéro CAS:
Poids moléculaire :
484.55
Code UNSPSC :
41116107
Nomenclature NACRES :
NA.24

Qualité

certified reference material
pharmaceutical secondary standard

Niveau de qualité

Famille d'API

fluticasone

CofA (certificat d'analyse)

current certificate can be downloaded

Conditionnement

pkg of 50 mg

Application(s)

pharmaceutical small molecule

Format

neat

Température de stockage

2-8°C

Vous recherchez des produits similaires ? Visite Guide de comparaison des produits

Description générale

Fluticasone Related Compound B is an impurity of the synthetic corticosteroid drug, fluticasone propionate. Fluticasone propionate is generally used as an inhalation medication for the treatment of asthma.
Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.

Application

Fluticasone Related Compound B may be used as a pharmaceutical reference standard for the determination of the analyte in bulk drug and pharmaceutical formulations by high performance liquid chromatography.
These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements.

Remarque sur l'analyse

These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.

Autres remarques

This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.

Note de bas de page

To see an example of a Certificate of Analysis for this material enter LRAB2754 in the Documents slot below. This is an example certificate only and may not be the lot that you receive.

Produit(s) apparenté(s)

Réf. du produit
Description
Tarif

Pictogrammes

Health hazard

Mention d'avertissement

Danger

Mentions de danger

Classification des risques

Resp. Sens. 1 - Skin Sens. 1

Code de la classe de stockage

11 - Combustible Solids

Classe de danger pour l'eau (WGK)

WGK 3

Point d'éclair (°F)

Not applicable

Point d'éclair (°C)

Not applicable


Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Comparative evaluation of the leukotriene receptor antagonist pranlukast versus the steroid inhalant fluticasone in the therapy of aged patients with mild bronchial asthma
Horiguchi T, et al.
Arzneimittelforschung, 57(02), 87-91 (2007)
Fluticasone propionate
USP42/NF37: United States Pharmacopeia and National Formulary
United States Pharmacopeia/National Formulary, 32(2), 1940-1940 (2014)
Method Development and Validation of Simultaneous Determination of Related Substances for Salmeterol Xinafoate and Fluticasone Propionate in Dry Powder Inhalers
Arzu C, et al.
Chromatography, 10(02), 87-91 (2017)

Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..

Contacter notre Service technique